No Data
No Data
Soochow Securities: "Implementation Plan for Supporting the Development of Innovative Drugs Across the Entire Chain" Approved, and the innovative drugs sector is expected to strengthen.
Soochow Securities released research reports stating that the specific provisions of the "Implementation Plan for Full-chain Support of Innovative Drug Development" are expected to be implemented soon. In addition, the innovative drug sector is currently at a historically relatively low level. In the second half of the year, there will be multiple catalysts such as the ESMO conference, WCLC conference, medical insurance negotiations, and expectations for the innovative drug sector going global, which may lead to a strong performance in the innovative drug sector.
Hong Kong stock market concept tracking | Heavy policies supporting the development of innovative drugs are introduced! The industry is expected to enter the fast lane of development (with concept stocks).
On July 5th, the State Council's executive meeting discussed and deployed the work related to promoting high-quality development of the digital economy, and approved the Implementation Plan for Supporting the Development of Innovative Drugs throughout the Whole Chain.
Beigene (06160) issued a total of 0.7363 million shares due to restricted stock units being granted.
Beigene (06160) announced that on June 30, 2024, due to restricted shares granted under the equity plan...
BeiGene Ltd Announces New Stock Grants
Beigene (06160.HK): Granted a total of 1760 American depositary share warrants and 56,600 restricted share units of American depositary shares.
Beigene (06160.HK) announced on July 3, that on June 28, 2024, the board of directors' compensation committee granted options to purchase a total of 1,760 American depositary shares and restricted stock units involving a total of 56,609 American depositary shares to 112 grantees in accordance with the terms of the 2016 equity incentive plan.
Express News | Beigene (06160) announced that on June 30, 2024, a total of approximately 736,300 shares will be issued based on the stock plan to award shares or options to participants (excluding directors of the issuer).